作者: Thomas J. Guzzo , Brian M. Levin , Richard Lee , Mengye Guo , Zhen Chen
DOI: 10.1016/J.UROLOGY.2007.09.027
关键词:
摘要: OBJECTIVES Recent studies have demonstrated that the percentage of positive prostate needle biopsies (PPBs) is an independent predictor biochemical failure (BF) after radical prostatectomy and external beam radiotherapy. Few confirmed this phenomenon in patients treated with permanent interstitial brachytherapy. We conducted analysis to determine clinical utility PPBs predicting BF brachytherapy for clinically localized cancer. METHODS The pathologic data from 245 hormone-naive Stage T1c-T2cNxM0 cancer who had undergone 1992 2002 at our institution were retrospectively evaluated. PPBs, preimplant prostate-specific antigen, biopsy Gleason score evaluated as predictors risk was calculated using logistic regression models. time assessed Cox proportional hazard models Kaplan-Meier estimates. RESULTS median study cohort 27%. 10.9% those a less than versus 26.2% greater median. A on multivariate (relative 2.3, 95% confidence interval 1.21 4.39, P = 0.011). In time-to-failure models, antigen level, significantly associated BF. CONCLUSIONS Our suggest undergoing along pretreatment level score, useful preoperative parameter